Global 23-valent Pneumococcal Vaccine Market
As the global economy mends, the 2021 growth of 23-valent Pneumococcal Vaccine will have signific ... Read More
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Streptococcus Pneumoniae Vaccine Annual Sales 2017-2028 2.1.2 World Current & Future Analysis for Streptococcus Pneumoniae Vaccine by Geographic Region, 2017, 2022 & 2028 2.1.3 World Current & Future Analysis for Streptococcus Pneumoniae Vaccine by Country/Region, 2017, 2022 & 2028 2.2 Streptococcus Pneumoniae Vaccine Segment by Type 2.2.1 7 -Valent 2.2.2 10 -Valent 2.2.3 13 -Valent 2.2.4 15 -Valent 2.2.5 23 -Valent 2.2.6 Other 2.3 Streptococcus Pneumoniae Vaccine Sales by Type 2.3.1 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2017-2022) 2.3.2 Global Streptococcus Pneumoniae Vaccine Revenue and Market Share by Type (2017-2022) 2.3.3 Global Streptococcus Pneumoniae Vaccine Sale Price by Type (2017-2022) 2.4 Streptococcus Pneumoniae Vaccine Segment by Application 2.4.1 Children under 2 Years of Age 2.4.2 Adults over 65 Years of Age 2.4.3 Addicted Smokers Between the Ages of 19 and 64 2.4.4 Other 2.5 Streptococcus Pneumoniae Vaccine Sales by Application 2.5.1 Global Streptococcus Pneumoniae Vaccine Sale Market Share by Application (2017-2022) 2.5.2 Global Streptococcus Pneumoniae Vaccine Revenue and Market Share by Application (2017-2022) 2.5.3 Global Streptococcus Pneumoniae Vaccine Sale Price by Application (2017-2022) 3 Global Streptococcus Pneumoniae Vaccine by Company 3.1 Global Streptococcus Pneumoniae Vaccine Breakdown Data by Company 3.1.1 Global Streptococcus Pneumoniae Vaccine Annual Sales by Company (2020-2022) 3.1.2 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Company (2020-2022) 3.2 Global Streptococcus Pneumoniae Vaccine Annual Revenue by Company (2020-2022) 3.2.1 Global Streptococcus Pneumoniae Vaccine Revenue by Company (2020-2022) 3.2.2 Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Company (2020-2022) 3.3 Global Streptococcus Pneumoniae Vaccine Sale Price by Company 3.4 Key Manufacturers Streptococcus Pneumoniae Vaccine Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Streptococcus Pneumoniae Vaccine Product Location Distribution 3.4.2 Players Streptococcus Pneumoniae Vaccine Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Streptococcus Pneumoniae Vaccine by Geographic Region 4.1 World Historic Streptococcus Pneumoniae Vaccine Market Size by Geographic Region (2017-2022) 4.1.1 Global Streptococcus Pneumoniae Vaccine Annual Sales by Geographic Region (2017-2022) 4.1.2 Global Streptococcus Pneumoniae Vaccine Annual Revenue by Geographic Region 4.2 World Historic Streptococcus Pneumoniae Vaccine Market Size by Country/Region (2017-2022) 4.2.1 Global Streptococcus Pneumoniae Vaccine Annual Sales by Country/Region (2017-2022) 4.2.2 Global Streptococcus Pneumoniae Vaccine Annual Revenue by Country/Region 4.3 Americas Streptococcus Pneumoniae Vaccine Sales Growth 4.4 APAC Streptococcus Pneumoniae Vaccine Sales Growth 4.5 Europe Streptococcus Pneumoniae Vaccine Sales Growth 4.6 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Growth 5 Americas 5.1 Americas Streptococcus Pneumoniae Vaccine Sales by Country 5.1.1 Americas Streptococcus Pneumoniae Vaccine Sales by Country (2017-2022) 5.1.2 Americas Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2022) 5.2 Americas Streptococcus Pneumoniae Vaccine Sales by Type 5.3 Americas Streptococcus Pneumoniae Vaccine Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Streptococcus Pneumoniae Vaccine Sales by Region 6.1.1 APAC Streptococcus Pneumoniae Vaccine Sales by Region (2017-2022) 6.1.2 APAC Streptococcus Pneumoniae Vaccine Revenue by Region (2017-2022) 6.2 APAC Streptococcus Pneumoniae Vaccine Sales by Type 6.3 APAC Streptococcus Pneumoniae Vaccine Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Streptococcus Pneumoniae Vaccine by Country 7.1.1 Europe Streptococcus Pneumoniae Vaccine Sales by Country (2017-2022) 7.1.2 Europe Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2022) 7.2 Europe Streptococcus Pneumoniae Vaccine Sales by Type 7.3 Europe Streptococcus Pneumoniae Vaccine Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Streptococcus Pneumoniae Vaccine by Country 8.1.1 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Country (2017-2022) 8.1.2 Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2022) 8.2 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Type 8.3 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Streptococcus Pneumoniae Vaccine 10.3 Manufacturing Process Analysis of Streptococcus Pneumoniae Vaccine 10.4 Industry Chain Structure of Streptococcus Pneumoniae Vaccine 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Streptococcus Pneumoniae Vaccine Distributors 11.3 Streptococcus Pneumoniae Vaccine Customer 12 World Forecast Review for Streptococcus Pneumoniae Vaccine by Geographic Region 12.1 Global Streptococcus Pneumoniae Vaccine Market Size Forecast by Region 12.1.1 Global Streptococcus Pneumoniae Vaccine Forecast by Region (2023-2028) 12.1.2 Global Streptococcus Pneumoniae Vaccine Annual Revenue Forecast by Region (2023-2028) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Streptococcus Pneumoniae Vaccine Forecast by Type 12.7 Global Streptococcus Pneumoniae Vaccine Forecast by Application 13 Key Players Analysis 13.1 Pfizer 13.1.1 Pfizer Company Information 13.1.2 Pfizer Streptococcus Pneumoniae Vaccine Product Offered 13.1.3 Pfizer Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.1.4 Pfizer Main Business Overview 13.1.5 Pfizer Latest Developments 13.2 Sanofi 13.2.1 Sanofi Company Information 13.2.2 Sanofi Streptococcus Pneumoniae Vaccine Product Offered 13.2.3 Sanofi Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.2.4 Sanofi Main Business Overview 13.2.5 Sanofi Latest Developments 13.3 GSK 13.3.1 GSK Company Information 13.3.2 GSK Streptococcus Pneumoniae Vaccine Product Offered 13.3.3 GSK Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.3.4 GSK Main Business Overview 13.3.5 GSK Latest Developments 13.4 Merck 13.4.1 Merck Company Information 13.4.2 Merck Streptococcus Pneumoniae Vaccine Product Offered 13.4.3 Merck Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.4.4 Merck Main Business Overview 13.4.5 Merck Latest Developments 13.5 Eli Lilly 13.5.1 Eli Lilly Company Information 13.5.2 Eli Lilly Streptococcus Pneumoniae Vaccine Product Offered 13.5.3 Eli Lilly Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.5.4 Eli Lilly Main Business Overview 13.5.5 Eli Lilly Latest Developments 13.6 AstraZeneca 13.6.1 AstraZeneca Company Information 13.6.2 AstraZeneca Streptococcus Pneumoniae Vaccine Product Offered 13.6.3 AstraZeneca Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.6.4 AstraZeneca Main Business Overview 13.6.5 AstraZeneca Latest Developments 13.7 Abera 13.7.1 Abera Company Information 13.7.2 Abera Streptococcus Pneumoniae Vaccine Product Offered 13.7.3 Abera Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.7.4 Abera Main Business Overview 13.7.5 Abera Latest Developments 13.8 S K Chemicals 13.8.1 S K Chemicals Company Information 13.8.2 S K Chemicals Streptococcus Pneumoniae Vaccine Product Offered 13.8.3 S K Chemicals Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.8.4 S K Chemicals Main Business Overview 13.8.5 S K Chemicals Latest Developments 13.9 Beijing Minhai Biotechnology 13.9.1 Beijing Minhai Biotechnology Company Information 13.9.2 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Product Offered 13.9.3 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.9.4 Beijing Minhai Biotechnology Main Business Overview 13.9.5 Beijing Minhai Biotechnology Latest Developments 13.10 Baxter 13.10.1 Baxter Company Information 13.10.2 Baxter Streptococcus Pneumoniae Vaccine Product Offered 13.10.3 Baxter Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.10.4 Baxter Main Business Overview 13.10.5 Baxter Latest Developments 13.11 Biken 13.11.1 Biken Company Information 13.11.2 Biken Streptococcus Pneumoniae Vaccine Product Offered 13.11.3 Biken Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.11.4 Biken Main Business Overview 13.11.5 Biken Latest Developments 13.12 Celgene Corporation 13.12.1 Celgene Corporation Company Information 13.12.2 Celgene Corporation Streptococcus Pneumoniae Vaccine Product Offered 13.12.3 Celgene Corporation Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.12.4 Celgene Corporation Main Business Overview 13.12.5 Celgene Corporation Latest Developments 13.13 Panacea Biotec 13.13.1 Panacea Biotec Company Information 13.13.2 Panacea Biotec Streptococcus Pneumoniae Vaccine Product Offered 13.13.3 Panacea Biotec Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.13.4 Panacea Biotec Main Business Overview 13.13.5 Panacea Biotec Latest Developments 13.14 Serum Institute of India 13.14.1 Serum Institute of India Company Information 13.14.2 Serum Institute of India Streptococcus Pneumoniae Vaccine Product Offered 13.14.3 Serum Institute of India Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.14.4 Serum Institute of India Main Business Overview 13.14.5 Serum Institute of India Latest Developments 13.15 Genentech 13.15.1 Genentech Company Information 13.15.2 Genentech Streptococcus Pneumoniae Vaccine Product Offered 13.15.3 Genentech Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.15.4 Genentech Main Business Overview 13.15.5 Genentech Latest Developments 13.16 Genocea Biosciences 13.16.1 Genocea Biosciences Company Information 13.16.2 Genocea Biosciences Streptococcus Pneumoniae Vaccine Product Offered 13.16.3 Genocea Biosciences Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.16.4 Genocea Biosciences Main Business Overview 13.16.5 Genocea Biosciences Latest Developments 13.17 ImmunoBiology 13.17.1 ImmunoBiology Company Information 13.17.2 ImmunoBiology Streptococcus Pneumoniae Vaccine Product Offered 13.17.3 ImmunoBiology Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.17.4 ImmunoBiology Main Business Overview 13.17.5 ImmunoBiology Latest Developments 13.18 Lupin 13.18.1 Lupin Company Information 13.18.2 Lupin Streptococcus Pneumoniae Vaccine Product Offered 13.18.3 Lupin Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.18.4 Lupin Main Business Overview 13.18.5 Lupin Latest Developments 13.19 Nuron Biotech 13.19.1 Nuron Biotech Company Information 13.19.2 Nuron Biotech Streptococcus Pneumoniae Vaccine Product Offered 13.19.3 Nuron Biotech Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.19.4 Nuron Biotech Main Business Overview 13.19.5 Nuron Biotech Latest Developments 13.20 Biogen 13.20.1 Biogen Company Information 13.20.2 Biogen Streptococcus Pneumoniae Vaccine Product Offered 13.20.3 Biogen Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.20.4 Biogen Main Business Overview 13.20.5 Biogen Latest Developments 13.21 Valneva Austria 13.21.1 Valneva Austria Company Information 13.21.2 Valneva Austria Streptococcus Pneumoniae Vaccine Product Offered 13.21.3 Valneva Austria Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.21.4 Valneva Austria Main Business Overview 13.21.5 Valneva Austria Latest Developments 13.22 Sinovac 13.22.1 Sinovac Company Information 13.22.2 Sinovac Streptococcus Pneumoniae Vaccine Product Offered 13.22.3 Sinovac Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022) 13.22.4 Sinovac Main Business Overview 13.22.5 Sinovac Latest Developments 14 Research Findings and Conclusion
List of Tables Table 1. Streptococcus Pneumoniae Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions) Table 2. Streptococcus Pneumoniae Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions) Table 3. Major Players of 7 -Valent Table 4. Major Players of 10 -Valent Table 5. Major Players of 13 -Valent Table 6. Major Players of 15 -Valent Table 7. Major Players of 23 -Valent Table 8. Major Players of Other Table 9. Global Streptococcus Pneumoniae Vaccine Sales by Type (2017-2022) & (K Units) Table 10. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2017-2022) Table 11. Global Streptococcus Pneumoniae Vaccine Revenue by Type (2017-2022) & ($ million) Table 12. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Type (2017-2022) Table 13. Global Streptococcus Pneumoniae Vaccine Sale Price by Type (2017-2022) & (US$/Unit) Table 14. Global Streptococcus Pneumoniae Vaccine Sales by Application (2017-2022) & (K Units) Table 15. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2022) Table 16. Global Streptococcus Pneumoniae Vaccine Revenue by Application (2017-2022) Table 17. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Application (2017-2022) Table 18. Global Streptococcus Pneumoniae Vaccine Sale Price by Application (2017-2022) & (US$/Unit) Table 19. Global Streptococcus Pneumoniae Vaccine Sales by Company (2020-2022) & (K Units) Table 20. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Company (2020-2022) Table 21. Global Streptococcus Pneumoniae Vaccine Revenue by Company (2020-2022) ($ Millions) Table 22. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Company (2020-2022) Table 23. Global Streptococcus Pneumoniae Vaccine Sale Price by Company (2020-2022) & (US$/Unit) Table 24. Key Manufacturers Streptococcus Pneumoniae Vaccine Producing Area Distribution and Sales Area Table 25. Players Streptococcus Pneumoniae Vaccine Products Offered Table 26. Streptococcus Pneumoniae Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 27. New Products and Potential Entrants Table 28. Mergers & Acquisitions, Expansion Table 29. Global Streptococcus Pneumoniae Vaccine Sales by Geographic Region (2017-2022) & (K Units) Table 30. Global Streptococcus Pneumoniae Vaccine Sales Market Share Geographic Region (2017-2022) Table 31. Global Streptococcus Pneumoniae Vaccine Revenue by Geographic Region (2017-2022) & ($ millions) Table 32. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Geographic Region (2017-2022) Table 33. Global Streptococcus Pneumoniae Vaccine Sales by Country/Region (2017-2022) & (K Units) Table 34. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Country/Region (2017-2022) Table 35. Global Streptococcus Pneumoniae Vaccine Revenue by Country/Region (2017-2022) & ($ millions) Table 36. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Country/Region (2017-2022) Table 37. Americas Streptococcus Pneumoniae Vaccine Sales by Country (2017-2022) & (K Units) Table 38. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2017-2022) Table 39. Americas Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2022) & ($ Millions) Table 40. Americas Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2017-2022) Table 41. Americas Streptococcus Pneumoniae Vaccine Sales by Type (2017-2022) & (K Units) Table 42. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2017-2022) Table 43. Americas Streptococcus Pneumoniae Vaccine Sales by Application (2017-2022) & (K Units) Table 44. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2022) Table 45. APAC Streptococcus Pneumoniae Vaccine Sales by Region (2017-2022) & (K Units) Table 46. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Region (2017-2022) Table 47. APAC Streptococcus Pneumoniae Vaccine Revenue by Region (2017-2022) & ($ Millions) Table 48. APAC Streptococcus Pneumoniae Vaccine Revenue Market Share by Region (2017-2022) Table 49. APAC Streptococcus Pneumoniae Vaccine Sales by Type (2017-2022) & (K Units) Table 50. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2017-2022) Table 51. APAC Streptococcus Pneumoniae Vaccine Sales by Application (2017-2022) & (K Units) Table 52. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2022) Table 53. Europe Streptococcus Pneumoniae Vaccine Sales by Country (2017-2022) & (K Units) Table 54. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2017-2022) Table 55. Europe Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2022) & ($ Millions) Table 56. Europe Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2017-2022) Table 57. Europe Streptococcus Pneumoniae Vaccine Sales by Type (2017-2022) & (K Units) Table 58. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2017-2022) Table 59. Europe Streptococcus Pneumoniae Vaccine Sales by Application (2017-2022) & (K Units) Table 60. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2022) Table 61. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Country (2017-2022) & (K Units) Table 62. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2017-2022) Table 63. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2022) & ($ Millions) Table 64. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2017-2022) Table 65. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Type (2017-2022) & (K Units) Table 66. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2017-2022) Table 67. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Application (2017-2022) & (K Units) Table 68. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2022) Table 69. Key Market Drivers & Growth Opportunities of Streptococcus Pneumoniae Vaccine Table 70. Key Market Challenges & Risks of Streptococcus Pneumoniae Vaccine Table 71. Key Industry Trends of Streptococcus Pneumoniae Vaccine Table 72. Streptococcus Pneumoniae Vaccine Raw Material Table 73. Key Suppliers of Raw Materials Table 74. Streptococcus Pneumoniae Vaccine Distributors List Table 75. Streptococcus Pneumoniae Vaccine Customer List Table 76. Global Streptococcus Pneumoniae Vaccine Sales Forecast by Region (2023-2028) & (K Units) Table 77. Global Streptococcus Pneumoniae Vaccine Sales Market Forecast by Region Table 78. Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Region (2023-2028) & ($ millions) Table 79. Global Streptococcus Pneumoniae Vaccine Revenue Market Share Forecast by Region (2023-2028) Table 80. Americas Streptococcus Pneumoniae Vaccine Sales Forecast by Country (2023-2028) & (K Units) Table 81. Americas Streptococcus Pneumoniae Vaccine Revenue Forecast by Country (2023-2028) & ($ millions) Table 82. APAC Streptococcus Pneumoniae Vaccine Sales Forecast by Region (2023-2028) & (K Units) Table 83. APAC Streptococcus Pneumoniae Vaccine Revenue Forecast by Region (2023-2028) & ($ millions) Table 84. Europe Streptococcus Pneumoniae Vaccine Sales Forecast by Country (2023-2028) & (K Units) Table 85. Europe Streptococcus Pneumoniae Vaccine Revenue Forecast by Country (2023-2028) & ($ millions) Table 86. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Forecast by Country (2023-2028) & (K Units) Table 87. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue Forecast by Country (2023-2028) & ($ millions) Table 88. Global Streptococcus Pneumoniae Vaccine Sales Forecast by Type (2023-2028) & (K Units) Table 89. Global Streptococcus Pneumoniae Vaccine Sales Market Share Forecast by Type (2023-2028) Table 90. Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions) Table 91. Global Streptococcus Pneumoniae Vaccine Revenue Market Share Forecast by Type (2023-2028) Table 92. Global Streptococcus Pneumoniae Vaccine Sales Forecast by Application (2023-2028) & (K Units) Table 93. Global Streptococcus Pneumoniae Vaccine Sales Market Share Forecast by Application (2023-2028) Table 94. Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions) Table 95. Global Streptococcus Pneumoniae Vaccine Revenue Market Share Forecast by Application (2023-2028) Table 96. Pfizer Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 97. Pfizer Streptococcus Pneumoniae Vaccine Product Offered Table 98. Pfizer Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 99. Pfizer Main Business Table 100. Pfizer Latest Developments Table 101. Sanofi Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 102. Sanofi Streptococcus Pneumoniae Vaccine Product Offered Table 103. Sanofi Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 104. Sanofi Main Business Table 105. Sanofi Latest Developments Table 106. GSK Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 107. GSK Streptococcus Pneumoniae Vaccine Product Offered Table 108. GSK Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 109. GSK Main Business Table 110. GSK Latest Developments Table 111. Merck Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 112. Merck Streptococcus Pneumoniae Vaccine Product Offered Table 113. Merck Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 114. Merck Main Business Table 115. Merck Latest Developments Table 116. Eli Lilly Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 117. Eli Lilly Streptococcus Pneumoniae Vaccine Product Offered Table 118. Eli Lilly Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 119. Eli Lilly Main Business Table 120. Eli Lilly Latest Developments Table 121. AstraZeneca Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 122. AstraZeneca Streptococcus Pneumoniae Vaccine Product Offered Table 123. AstraZeneca Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 124. AstraZeneca Main Business Table 125. AstraZeneca Latest Developments Table 126. Abera Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 127. Abera Streptococcus Pneumoniae Vaccine Product Offered Table 128. Abera Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 129. Abera Main Business Table 130. Abera Latest Developments Table 131. S K Chemicals Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 132. S K Chemicals Streptococcus Pneumoniae Vaccine Product Offered Table 133. S K Chemicals Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 134. S K Chemicals Main Business Table 135. S K Chemicals Latest Developments Table 136. Beijing Minhai Biotechnology Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 137. Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Product Offered Table 138. Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 139. Beijing Minhai Biotechnology Main Business Table 140. Beijing Minhai Biotechnology Latest Developments Table 141. Baxter Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 142. Baxter Streptococcus Pneumoniae Vaccine Product Offered Table 143. Baxter Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 144. Baxter Main Business Table 145. Baxter Latest Developments Table 146. Biken Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 147. Biken Streptococcus Pneumoniae Vaccine Product Offered Table 148. Biken Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 149. Biken Main Business Table 150. Biken Latest Developments Table 151. Celgene Corporation Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 152. Celgene Corporation Streptococcus Pneumoniae Vaccine Product Offered Table 153. Celgene Corporation Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 154. Celgene Corporation Main Business Table 155. Celgene Corporation Latest Developments Table 156. Panacea Biotec Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 157. Panacea Biotec Streptococcus Pneumoniae Vaccine Product Offered Table 158. Panacea Biotec Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 159. Panacea Biotec Main Business Table 160. Panacea Biotec Latest Developments Table 161. Serum Institute of India Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 162. Serum Institute of India Streptococcus Pneumoniae Vaccine Product Offered Table 163. Serum Institute of India Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 164. Serum Institute of India Main Business Table 165. Serum Institute of India Latest Developments Table 166. Genentech Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 167. Genentech Streptococcus Pneumoniae Vaccine Product Offered Table 168. Genentech Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 169. Genentech Main Business Table 170. Genentech Latest Developments Table 171. Genocea Biosciences Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 172. Genocea Biosciences Streptococcus Pneumoniae Vaccine Product Offered Table 173. Genocea Biosciences Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 174. Genocea Biosciences Main Business Table 175. Genocea Biosciences Latest Developments Table 176. ImmunoBiology Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 177. ImmunoBiology Streptococcus Pneumoniae Vaccine Product Offered Table 178. ImmunoBiology Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 179. ImmunoBiology Main Business Table 180. ImmunoBiology Latest Developments Table 181. Lupin Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 182. Lupin Streptococcus Pneumoniae Vaccine Product Offered Table 183. Lupin Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 184. Lupin Main Business Table 185. Lupin Latest Developments Table 186. Nuron Biotech Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 187. Nuron Biotech Streptococcus Pneumoniae Vaccine Product Offered Table 188. Nuron Biotech Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 189. Nuron Biotech Main Business Table 190. Nuron Biotech Latest Developments Table 191. Biogen Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 192. Biogen Streptococcus Pneumoniae Vaccine Product Offered Table 193. Biogen Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 194. Biogen Main Business Table 195. Biogen Latest Developments Table 196. Valneva Austria Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 197. Valneva Austria Streptococcus Pneumoniae Vaccine Product Offered Table 198. Valneva Austria Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 199. Valneva Austria Main Business Table 200. Valneva Austria Latest Developments Table 201. Sinovac Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors Table 202. Sinovac Streptococcus Pneumoniae Vaccine Product Offered Table 203. Sinovac Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022) Table 204. Sinovac Main Business Table 205. Sinovac Latest Developments List of Figures Figure 1. Picture of Streptococcus Pneumoniae Vaccine Figure 2. Streptococcus Pneumoniae Vaccine Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Streptococcus Pneumoniae Vaccine Sales Growth Rate 2017-2028 (K Units) Figure 7. Global Streptococcus Pneumoniae Vaccine Revenue Growth Rate 2017-2028 ($ Millions) Figure 8. Streptococcus Pneumoniae Vaccine Sales by Region (2021 & 2028) & ($ millions) Figure 9. Product Picture of 7 -Valent Figure 10. Product Picture of 10 -Valent Figure 11. Product Picture of 13 -Valent Figure 12. Product Picture of 15 -Valent Figure 13. Product Picture of 23 -Valent Figure 14. Product Picture of Other Figure 15. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type in 2021 Figure 16. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Type (2017-2022) Figure 17. Streptococcus Pneumoniae Vaccine Consumed in Children under 2 Years of Age Figure 18. Global Streptococcus Pneumoniae Vaccine Market: Children under 2 Years of Age (2017-2022) & (K Units) Figure 19. Streptococcus Pneumoniae Vaccine Consumed in Adults over 65 Years of Age Figure 20. Global Streptococcus Pneumoniae Vaccine Market: Adults over 65 Years of Age (2017-2022) & (K Units) Figure 21. Streptococcus Pneumoniae Vaccine Consumed in Addicted Smokers Between the Ages of 19 and 64 Figure 22. Global Streptococcus Pneumoniae Vaccine Market: Addicted Smokers Between the Ages of 19 and 64 (2017-2022) & (K Units) Figure 23. Streptococcus Pneumoniae Vaccine Consumed in Other Figure 24. Global Streptococcus Pneumoniae Vaccine Market: Other (2017-2022) & (K Units) Figure 25. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2022) Figure 26. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Application in 2021 Figure 27. Streptococcus Pneumoniae Vaccine Revenue Market by Company in 2021 ($ Million) Figure 28. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Company in 2021 Figure 29. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Geographic Region (2017-2022) Figure 30. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Geographic Region in 2021 Figure 31. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Region (2017-2022) Figure 32. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Country/Region in 2021 Figure 33. Americas Streptococcus Pneumoniae Vaccine Sales 2017-2022 (K Units) Figure 34. Americas Streptococcus Pneumoniae Vaccine Revenue 2017-2022 ($ Millions) Figure 35. APAC Streptococcus Pneumoniae Vaccine Sales 2017-2022 (K Units) Figure 36. APAC Streptococcus Pneumoniae Vaccine Revenue 2017-2022 ($ Millions) Figure 37. Europe Streptococcus Pneumoniae Vaccine Sales 2017-2022 (K Units) Figure 38. Europe Streptococcus Pneumoniae Vaccine Revenue 2017-2022 ($ Millions) Figure 39. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales 2017-2022 (K Units) Figure 40. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue 2017-2022 ($ Millions) Figure 41. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Country in 2021 Figure 42. Americas Streptococcus Pneumoniae Vaccine Revenue Market Share by Country in 2021 Figure 43. United States Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 44. Canada Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 45. Mexico Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 46. Brazil Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 47. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Region in 2021 Figure 48. APAC Streptococcus Pneumoniae Vaccine Revenue Market Share by Regions in 2021 Figure 49. China Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 50. Japan Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 51. South Korea Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 52. Southeast Asia Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 53. India Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 54. Australia Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 55. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Country in 2021 Figure 56. Europe Streptococcus Pneumoniae Vaccine Revenue Market Share by Country in 2021 Figure 57. Germany Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 58. France Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 59. UK Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 60. Italy Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 61. Russia Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 62. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Country in 2021 Figure 63. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue Market Share by Country in 2021 Figure 64. Egypt Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 65. South Africa Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 66. Israel Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 67. Turkey Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 68. GCC Country Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions) Figure 69. Manufacturing Cost Structure Analysis of Streptococcus Pneumoniae Vaccine in 2021 Figure 70. Manufacturing Process Analysis of Streptococcus Pneumoniae Vaccine Figure 71. Industry Chain Structure of Streptococcus Pneumoniae Vaccine Figure 72. Channels of Distribution Figure 73. Distributors Profiles
As the global economy mends, the 2021 growth of 23-valent Pneumococcal Vaccine will have signific ... Read More
As the global economy mends, the 2021 growth of 13-Valent Pneumococcal Polysaccharide Conjugate V ... Read More
As the global economy mends, the 2021 growth of Hot and Sour Noodles will have significant change ... Read More
As the global economy mends, the 2021 growth of Automotive Exhaust Catalytic Materials will have ... Read More